These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 7484280)

  • 1. Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells.
    Inaba M; Terada M; Koyama H; Yoshida O; Ishimura E; Kawagishi T; Okuno Y; Nishizawa Y; Otani S; Morii H
    J Bone Miner Res; 1995 Jul; 10(7):1050-6. PubMed ID: 7484280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors.
    Lajeunesse D; Delalandre A; Guggino SE
    J Bone Miner Res; 2000 May; 15(5):894-901. PubMed ID: 10804019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and biochemical evidence for the regulation of osteocalcin secretion by potassium channels in human osteoblast-like MG-63 cells.
    Moreau R; Aubin R; Lapointe JY; Lajeunesse D
    J Bone Miner Res; 1997 Dec; 12(12):1984-92. PubMed ID: 9421231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells.
    Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J
    J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells.
    Wang DS; Yamazaki K; Nohtomi K; Shizume K; Ohsumi K; Shibuya M; Demura H; Sato K
    J Bone Miner Res; 1996 Apr; 11(4):472-9. PubMed ID: 8992878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
    Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
    Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
    Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
    J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3.
    Mosavin R; Mellon WS
    Arch Biochem Biophys; 1996 Aug; 332(1):142-52. PubMed ID: 8806719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transforming growth factor beta 1 on the regulation of osteocalcin synthesis in human MG-63 osteosarcoma cells.
    Pirskanen A; Jääskeläinen T; Mäenpää PH
    J Bone Miner Res; 1994 Oct; 9(10):1635-42. PubMed ID: 7817811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
    Sterck JG; Klein-Nulend J; Burger EH; Lips P
    J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
    Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
    J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of calcipotriol (MC 903), a novel vitamin D3 analog, on human bone-derived cells: comparison with 1,25-dihydroxyvitamin D3.
    Evans DB; Thavarajah M; Binderup L; Kanis JA
    J Bone Miner Res; 1991 Dec; 6(12):1307-15. PubMed ID: 1792941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of osteocalcin and its propeptide from human osteoblastic cells: dissociation of the secretory patterns of osteocalcin and its propeptide.
    Hosoda K; Kanzaki S; Eguchi H; Kiyoki M; Yamaji T; Koshihara Y; Shiraki M; Seino Y
    J Bone Miner Res; 1993 May; 8(5):553-65. PubMed ID: 8511982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha decreases 1,25-dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells.
    Mayur N; Lewis S; Catherwood BD; Nanes MS
    J Bone Miner Res; 1993 Aug; 8(8):997-1003. PubMed ID: 8213262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.
    Scheven BA; van der Veen MJ; Damen CA; Lafeber FP; Van Rijn HJ; Bijlsma JW; Duursma SA
    J Bone Miner Res; 1995 Jun; 10(6):874-80. PubMed ID: 7572311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.